Cipla, Lupin hunt for loans to back US acquisitions
Two Indian pharmaceutical companies, Cipla and Lupin, are sounding out banks for loans to fund recent acquisitions in the US.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article:
- ✔ 4,000 annual insights
- ✔ 700+ notes and long-form analyses
- ✔ 4 capital markets databases
- ✔ Daily newsletters across markets and asset classes
- ✔ 2 weekly podcasts